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The aim of the present prospective study was to evaluate the predictive value of elastography in benign thyroid nodules of patients
affected byHashimoto’s thyroiditis (HT). From January 2011 to January 2012, 242 nodules in patients affected byHTwere submitted
to fine needle aspiration cytology (FNAC). All of the patients underwent sonography and elastography performed before FNAC.
230 (95%) nodules were benign, 8 papillary cancers, and 4 follicular lesions. Score 1 was found in 79.1% of benign lesions (sensitivity
79.1%; specificity 66.7%; PPV 97.8%; NPV 14.3%; accuracy 78.5%; 𝑝 < 0.05). In order to evaluate the outcome of thyroid ultrasound
echogenicity in relation to elastography features of nodule(s), all the patients with benign nodules were stratified according to
their hypoechoic pattern of thyroid (mild-moderate and severe). Following stratification score 1 was found in 84.2% of benign
nodules (sensitivity 75.0%; specificity 88.9%; PPV 27.3%;NPV 98.4%; accuracy 88.2%;𝑝 < 0.0001) of patients with amild-moderate
ultrasound thyroid hypoechogenicity, whereas it was found in 60% of benign nodules (𝑝 = 0.715) of patients with a marked
thyroid hypoechogenicity. Elastography appears to have limited value in detecting thyroid cancer in patients affected byHashimoto’s
thyroiditis with severe hypoechoic thyroid tissue.
1. Introduction
Hashimoto’s thyroiditis (HT), also known as chronic lym-
phocytic thyroiditis, is an autoimmune disease characterized
by lymphocytic infiltration of the gland and production of
autoantibodies that target thyroid peroxidase and/or thy-
roglobulin, resulting in tissue destruction and progressive
loss of thyroid function [1].
After ultrasound (US) introduction into clinical practice
in the late 1960s, thyroid ultrasonography proved to be very
effective in the diagnostic approach to thyroid disorders
[2–4]. Many studies have investigated whether the ultra-
sonographic characteristics of thyroid nodules are useful
indicators of histological malignancy.
Overall, these investigations suggest a few ultrasono-
graphic features that are significantly more frequent in
malignant than in benign thyroid nodules, and some have
tried to define a set of characteristics that identify nodules at
higher risk of malignancy [5].
The characteristic US pattern of Hashimoto’s glands con-
sists of an array of tiny hypoechoic nodules that may become
confluent, interspersed with echogenic fibrous bands [6];
nevertheless, US should be interpreted with caution due to
the diffuse heterogeneity and the presence of pseudonodules
related to ongoing inflammation. Elastography is a method
which assesses the risk of the malignancy and provides
information about the degree of hardness in tissue. Recently
elastography has been proposed as a new technique for
differentiating pseudonodules from nodules in HT [7] and
benign frommalignant lesions of thyroid gland [5, 8–10]. HT
is able to change the hardness of the thyroid tissue. There
have been few studies that have shown using elastography
that HT is able to change the hardness of the thyroid gland
decreasing its capacity to distinguish benign from malignant
nodule [11, 12].
The aim of the present prospective study was to evaluate
the predictive value of elastography in the characterization of
benign thyroid nodules of patients affected by HT.
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Figure 1: (a) Hashimoto’s thyroiditis with mild sonographic hypoechogenicity. (b) Hashimoto’s thyroiditis with severe sonographic
hypoechogenicity.
2. Materials and Methods
From January 2011 to January 2012, 250 consecutive patients
affected by HT with at least one solid nodule were submit-
ted to fine needle aspiration cytology (FNAC). Cases were
selected from patients referred to our thyroid unit for US-
guided FNAC. The selection criteria were as follows: (1)
indication to FNAC in accordance with the major guidelines
[5, 14]; (2) positive test for thyroglobulin antibody (TgAb)
and/or thyroid peroxidase antibody (TPOAb) and a thyroid
gland with hypoechoic pattern at US evaluation.
All of the patients underwent sonography and elastogra-
phy performed by the same skilled sonographer (CC) before
US-guided FNAC. Thyroid sonography and elastography
were performed with a real-time instrument (Vision 900;
HitachiMedical System, Tokyo, Japan) equippedwith a linear
probe with a central frequency of 6–13MHz.
The sonographic hypoechogenicity of thyroid gland (Fig-
ures 1(a) and 1(b)) was classified from mild-moderate to
severe in accordance with literature [15–18].
Findings at elastography were classified according to
the elasticity scores by Rago et al. [13]. Briefly, score 1
indicated nodules with high elasticity, score 2 nodules with
intermediate elasticity, and score 3 nodules with low elastic-
ity (Table 1). To minimize the intraobserver variability, the
freehand compression applied on the neck was standardized
by real-time measurement displayed on a numeric scale
(graded 1–5) to maintain an intermediated level optimal for
elastographic evaluation [6, 8].
The serum concentrations of TgAb (normal range:
<60U/mL) and TPOAb (normal range: <60U/mL) were
measured using immunochemiluminescent assays employ-
ing commercial kits (Brahms, Hennigsdorf, Germany).
All patients gave their informed consent to participate
in the study, which was performed in accordance with the
Declaration of Helsinki.
All data were analyzed with SPSS version 17 software
(SPSS Inc., Chicago, IL). Comparisons between groups were
performed by an analysis of variance general linear model; a
𝜒
2 test was used for categorical variables. Statistical signifi-
cance was considered at 𝑝 < 0.05.
Table 1: The applied standard elastography color scoring system
according to Rago criteria [13]. A score of 1 indicates even elasticity
in the whole nodule, score 2 elasticity only at the peripheral part
of the nodule, and score 3 no elasticity in the nodule and in the
posterior shadowing.
Score
1 Elasticity in the whole nodule
2 Intermediate elasticity in the nodule
3 Low elasticity in the nodule
Table 2: Elasticity score of the 242 nodules submitted to cytology
that resulted in benign nodules or carcinoma.
Elasticity score Benign (𝑛) Cancer (𝑛) Tot. (𝑛)
Score 1 182 2 184
Score 2 39 5 44
Score 3 9 5 14
3. Results
Two hundred fifty consecutive patients (202 female, 48male),
mean age 52.2 ± 11.2 years, were submitted to US-guided
FNAC.
Of the 262 nodules submitted to cytology, 20 (7.6%)
appeared to be nondiagnostic, and as a consequence 16
patients were excluded from the study. Among 234 patients
two hundred forty-two nodules were collected: 230 (95%)
were benign, 8 papillary cancers, and 4 follicular lesions.
Histology confirmed 8 papillary and 4 follicular cancers.
The lesions classified as scores 1, 2, and 3 on elastography
are listed in Table 2.
Score 1 was found in 182/230 (79.1%) of benign lesions
(sensitivity 79.1%; specificity 66.7%; positive predictive value
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Figure 2: Elasticity score in nodules with benign diagnostic cytol-
ogy in relation to thyroid hypoechogenicity pattern.
97.8%; negative predictive value 14.3%; accuracy 78.5%; 𝑝 <
0.05).
All 227 patients with benign nodules were stratified in
accordance with the echogenic pattern of thyroid gland
(mild-moderate/severe): 128 (56%) patients presented amild-
moderate thyroid echogenicity (Group A) and 99 (44%) a
severe one (Group B). The two groups were then stratified
in accordance with the elastographic scoring of the nodule
(scores 1, 2, and 3). The two groups were superimposable for
gender (86/42 versus 64/35 F/M), age (53.1 ± 12.8 versus 49.6
± 10, years), and TSH values (3.9 ± 1.1 versus 4.0 ± 0.9mU/L).
Following stratification, a significant different behavior
emerged in the two groups (Figure 2). In detail, score 1 was
found in 84.2% of benign nodules of patients with a mild-
moderate ultrasound thyroid hypoechogenicity (sensitivity
75.0%; specificity 88.9%; positive predictive value 27.3%; neg-
ative predictive value 98.4%; accuracy 88.2%;𝑝 < 0.0001) and
in 60% of patients with a marked thyroid hypoechogenicity
(sensitivity 50.0%; specificity 62.8%; positive predictive value
5.9%; negative predictive value 96.2%; accuracy 62.2%; 𝑝 =
0.715).
4. Discussion
As described by Gutekunst et al. thirty years ago HT is
associated with a diffuse reduction in thyroid echo levels
(hypoechogenicity) [19], with a correlation between serum
TPOAb levels and the degree of hypoechogenicity [18, 20],
that have been classified from mild-moderate to severe [17,
18]. After US introduction into clinical practice in the late
nineteen sixties thyroid ultrasonography proved to be very
effective in the diagnostic approach to thyroid disease [21].
Elastography has been proposed as a new and promising
technique for thyroid nodules evaluation [8–10, 13]. The
first evidence suggested that interobserver agreement is not
reliable in the diagnosis of malignant lesions but recent
data clearly shows a good interobserver and intraobserver
reproducibility in detecting thyroid cancer [22, 23].
Magri et al. evidenced that shear wave elastography
correctly defined the elasticity of thyroid nodules indepen-
dently of the coexistence of autoimmune thyroiditis, being
able to differentiate nodular tissue from the surrounding
parenchyma [6].The results of the present study confirm that
elastography is effective in distinguishing between benign
and malignant nodules in patients affected by HT, showing
however a lack of accuracy in patients affected by HT pre-
senting diffuse marked hypoechoic thyroid echo-structure
(i.e., severe sonographic thyroid hypoechogenicity). On the
contrary, two recent studies have shown that strain index
reflects malignancy better than the elastoscore inHT patients
[11, 12].
Taking into account the elastography performance in
our patients without stratification by sonographic hypoe-
chogenicity, our results also showed a lack of accuracy, but
for the first time, we showed that elastography has a high
performance when the thyroid echogenicity is not severe.
As already reported by Pedersen et al. [24] stronger
inflammatory process has been shown in severe sonographic
thyroid hypoechogenicity due to the diffuse infiltration of the
thyroid parenchyma with lymphocytes and fibrosis [20, 25].
It is conceivable that a benign process, likely represented
by nodular fibrosis, is responsible for the hard elastographic
pattern of many thyroid nodules in patients with HT. In fact,
histologically proven fibrotic nodules of the thyroid appear
to be characterized by a high stiffness index at elastographic
evaluation [26] and several hard nodules were detected in
patients previously submitted to radioiodine treatment which
is known to induce fibrosis [27]. Taking into account these
studies, we have hypothesized that higher inflammatory
process, lymphocytic infiltration, and fibrosis characterize
HT with severe sonographic thyroid hypoechogenicity, but
these reactions are also present in benign nodule(s) therefore
reducing the accuracy of elastographic evaluation in these
patients. Our results are in accordance with those of Scacchi
et al. obtained in acromegalic patients, who showed that
higher fibrosis developed in acromegalic thyroid patients
justifying the worst performance of elastography in detecting
cancer [28].
The present study has few limitations; firstly no histo-
logical data of benign nodules are given and secondly there
is the relative small size of patients enrolled in the study.
Another potential confounding factor may be the possibility
that “benign nodules” were represented by pseudonodular
fibrotic infiltration.
Unfortunately, we do not have histological data about
cytologically proven benign nodule(s). Only a small number
of patients (𝑛 = 26) with large benign nodules were
submitted to thyroidectomy and in all these patients histol-
ogy confirmed the benign nature of the lesions (data not
shown).However, wemust underline the accuracy in terms of
sensitivity, specificity, and false negative and positive rate of
FNAC [29, 30] to consider this procedure the gold-standard
in differentiating benign from malignant thyroid nodules in
many guidelines [5, 14]. Moreover, not only cytology [29, 30]
but also elastography [13, 26] well distinguishes true nodules
from pseudonodular ones. For these reasons we believe that
the lack of histological data in our study cannot diminish the
value of our results. Prospective large studies are needed to
confirm our observation.
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In conclusion our study has demonstrated a high preva-
lence of hard thyroid nodule at elastography evaluation in
patients with HT. Interestingly this is particularly evident
when the hypoechoic pattern of thyroid gland is severe, sug-
gesting an extensive infiltration of the thyroid parenchyma
with lymphocytes and fibrosis. The hypothesis that nodular
fibrosis might account for this elastography pattern is con-
ceivable but needs histopathological confirmation. Elastog-
raphy evidences a lack of accuracy when it is performed in
patients affected by HT presenting diffuse severe hypoechoic
thyroid echo-structure.
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